US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist

3.460
+0.110+3.28%

Trading Oct 15 10:10 ET

104.40MMarket Cap-1205P/E (TTM)

Relmada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relmada Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2020/Q3	-- / 0.000	--
--	2020/Q2	-- / 0.000	--
Aug 7, 2024	2024/Q2	0.000 / 0.000	--
May 8, 2024	2024/Q1	0.000 / 0.000	--
Mar 19, 2024	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2020/Q3-- / 0.000--

--2020/Q2-- / 0.000--

Aug 7, 20242024/Q20.000 / 0.000--

May 8, 20242024/Q10.000 / 0.000--

Mar 19, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Relmada Therapeutics Earnings Reports

Relmada Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7 16:10 ET

Relmada Therapeutics | 10-Q: Q1 2024 Earnings Report

May 8 16:13 ET

Relmada Therapeutics | 10-K: FY2023 Annual Report

Mar 19 16:11 ET

Relmada Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 8, 2023 16:05 ET

Analyst Rating

Updated: Oct 15, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall